BRCA-MUTATED OVARIAN CARCINOMA
Clinical trials for BRCA-MUTATED OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BRCA-MUTATED OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for BRCA-MUTATED OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early-phase trial is testing the drug olaparib in 15 people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to see if taking olaparib for two cycles can safely shrink tumors and stop them from growing. Olap…
Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Can family testing prevent ovarian cancer? new study investigates.
Knowledge-focused OngoingThis study tracks how often relatives of ovarian cancer patients with certain gene mutations (like BRCA) get tested themselves. The goal is to see if 'cascade testing' helps find more at-risk family members so they can take steps to prevent cancer. About 118 patients and their re…
Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC